RUNX1 is known to be a putative target gene of MLL fusions, and was highly expressed in MLL-AF4 ALL cases, when compared with normal bone marrow cells (Guenther et al., 2008; Krivtsov et al., 2008). The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.